Following several requests for advice on the development of medicinal products in the same therapeutic area, a ‘ Points to Consider ’ paper on Clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome (CPMP/ EWP/ 504/ 97) was prepared and issued, addressing the key points in the clinical development of such medicinal products.